 |
 |

Development of Novel Medications for Use in the Treatment of Obesity in Children Will Be Directed by Delineating Controls of Energy Homeostasis
Arch Pediatr Adolesc Med. 2003;157:721.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
THIS ISSUE of the ARCHIVES highlights the current pandemic of obesity, and its resultant complications, in children and adolescents. What is to be done about this alarming situation? Clearly, there is no single easy answer to a complex matter that likely has multiple etiologic risk factors.
Future attention must be paid to both the prevention and treatment of childhood obesity. However, as many will know from personal experience, it is not clear what are the most appropriate interventions. Even very small discrepancies in energy intake will result, in the long run, in excess weight gain.1 Reduced intake, increased exercise, and the changes in lifestyle that are advocated to achieve these goals are difficultif not impossiblefor many to maintain for protracted periods of time.
For many, the concept of a medication taken either to suppress appetite or encourage satiety holds attraction as an alternate approach for the prevention and treatment of . . . [Full Text of this Article]
Philip M. Sherman, MD, FRCPC
Research Institute Hospital for Sick Children University of Toronto 555 University Ave Toronto, Ontario Canada M5G 1X8 (e-mail: philip.sherman@sickkids.on.ca)
Stanley H. Zlotkin, MD, PhD, FRCPC
Toronto
|